Duff & Phelps Investment Management Co Boosted Mplx LP (MPLX) Stake; Mirati Therapeutics (MRTX) Sentiment Is 1.17

February 15, 2018 - By Michael Collier

Duff & Phelps Investment Management Co increased Mplx Lp (MPLX) stake by 16.86% reported in 2017Q3 SEC filing. Duff & Phelps Investment Management Co acquired 263,800 shares as Mplx Lp (MPLX)’s stock declined 7.56%. The Duff & Phelps Investment Management Co holds 1.83M shares with $64.01M value, up from 1.56M last quarter. Mplx Lp now has $29.45B valuation. The stock increased 0.44% or $0.16 during the last trading session, reaching $36.61. About 131,254 shares traded. MPLX LP (NYSE:MPLX) has risen 11.48% since February 15, 2017 and is uptrending. It has underperformed by 5.22% the S&P500.

Mirati Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of oncology products. The company has market cap of $798.42 million. The companyÂ’s clinical stage product candidates include glesatinib, an orally-bioavailable, potent, small molecule kinase inhibitor that is in Phase II clinical trials for the treatment of non-small cell lung cancer patients with genetic alterations of MET; and in Phase Ib clinical trials in patients with genetic alterations of MET and Axl in NSCLC and other solid tumors. It currently has negative earnings. The Company’s clinical stage product candidates also comprise sitravatinib, an orally-bioavailable, potent, small molecule spectrum-selective kinase inhibitor, which is in Phase II clinical trials for the treatment of solid tumors, such as NSCLC and metastatic Renal Cell Carcinoma, as well as in Phase Ib clinical trials to treat NSCLC patients with RET, CHR4q12, CBL, and AXL genetic alterations; and mocetinostat, an orally administered spectrum-selective Class 1 histone deacetylase inhibitor, which is in Phase Ib/II clinical trials in combination with durvalumab for the treatment of patients with NSCLC.

Broadfin Capital Llc holds 4.31% of its portfolio in Mirati Therapeutics, Inc. for 2.49 million shares. Venbio Select Advisor Llc owns 3.71 million shares or 3.37% of their US portfolio. Moreover, Cormorant Asset Management Llc has 2.07% invested in the company for 1.00 million shares. The New York-based Baker Bros. Advisors Lp has invested 0.22% in the stock. Element Capital Management Llc, a New York-based fund reported 17,422 shares.

Analysts await Mirati Therapeutics, Inc. (NASDAQ:MRTX) to report earnings on March, 8. They expect $-0.65 earnings per share, up 34.34% or $0.34 from last year’s $-0.99 per share. After $-0.65 actual earnings per share reported by Mirati Therapeutics, Inc. for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Since January 1, 0001, it had 0 insider purchases, and 5 selling transactions for $1.02 million activity.

The stock increased 0.35% or $0.1 during the last trading session, reaching $28.6. About 47,253 shares traded. Mirati Therapeutics, Inc. (MRTX) has declined 76.51% since February 15, 2017 and is downtrending. It has underperformed by 93.21% the S&P500.

Duff & Phelps Investment Management Co decreased Sony Corp (NYSE:SNE) stake by 38,059 shares to 157,906 valued at $5.89M in 2017Q3. It also reduced Nextera Energy Inc (NYSE:NEE) stake by 36,120 shares and now owns 1.11M shares. Eversource Energy was reduced too.

Investors sentiment decreased to 1.04 in Q3 2017. Its down 0.22, from 1.26 in 2017Q2. It worsened, as 26 investors sold MPLX shares while 79 reduced holdings. 15 funds opened positions while 94 raised stakes. 258.81 million shares or 4.21% more from 248.36 million shares in 2017Q2 were reported. 124 were accumulated by Hanson Mcclain Inc. Sterling Limited Liability accumulated 8,710 shares. Enterprise Fincl Svcs has 2,784 shares. Cibc Asset Incorporated has invested 0% in MPLX LP (NYSE:MPLX). Highstreet Asset Inc reported 217 shares or 0% of all its holdings. Wealthtrust reported 200 shares. Walleye Trading Limited Liability, Minnesota-based fund reported 26,340 shares. E&G Advsrs LP holds 7,085 shares or 0.11% of its portfolio. Salient Ltd Limited Liability Company accumulated 4.69 million shares or 3.63% of the stock. Baldwin Brothers Ma invested in 12,796 shares. Avenir has invested 0.8% of its portfolio in MPLX LP (NYSE:MPLX). Rafferty Asset Mgmt Ltd Company holds 16,242 shares. Commonwealth Of Pennsylvania Pub School Empls Retrmt System reported 3.92M shares or 2.02% of all its holdings. Tortoise Capital Advsrs Lc reported 22.79M shares. Moreover, Freestone Cap Ltd Liability Company has 0.4% invested in MPLX LP (NYSE:MPLX).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Michael Collier

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: